Stachartin D exhibits significant potential in pharmaceutical applications, particularly in the development of anti-inflammatory and antimicrobial agents. It has demonstrated inhibitory activity against certain pathogenic bacteria and fungi, making it a candidate for use in topical treatments. Additionally, its structural properties support further exploration in drug delivery systems, where it may enhance the stability and bioavailability of active ingredients. Research also suggests possible antitumor effects, contributing to its evaluation in oncology-related formulations. Its natural origin and low toxicity profile favor its use in medicinal and cosmetic products requiring biocompatible components.